Executive Summary

Oct 2019
PROSPECTS
Self-medication drives growth for analgesics

In 2019, analgesics in Tunisia were mainly used for the treatment of headaches, fever, colds and flu, with OTC analgesics being the preferred option. Many Tunisians led extremely stressful lifestyles that included hours in fronts of screens.

An increase in choice drives growth for paediatric analgesics

Driven by the increasing adoption of analgesics to treat childhood illnesses, paediatric analgesics is expected to register healthy retail value growth over the forecast period. Paediatric acetaminophen, aspirin and topical analgesics/anaesthetic will lead future growth, fuelled by increasing competition triggered by a variety of brands including Aspégic.

Distribution of analgesics dominated by chemists/pharmacies

In Tunisia, analgesics as well as other healthcare items are exclusively distributed through chemist/pharmacies and health and beauty specialist retailers, approved and accredited by the authorities. During the forecast period, chemists/pharmacies will therefore maintain the majority share of analgesics value sales.

COMPETITIVE LANDSCAPE
2019 shows positive results for Sanofi-Aventis Pharma

In 2019, Sanofi-Aventis Pharma Tunisie continued to lead analgesics with sales driven by a solid pricing strategy partnered with the wide availability of its offerings. Moreover, its success can also be attributed to its long-standing presence, good reputation and strong consumer loyalty.

Lack of innovation in analgesics as major players suffer against cheap alternatives

Innovation was limited in analgesics in Tunisia, with no real changes in 2019. Given the absence of advertising support, branded analgesics competed against generic items in Tunisia, and suffered from the increasing presence of cheap alternatives.

Manufacturing global brands locally remains a solution to rising prices

Increasing awareness of health and wellbeing helped to overcome the higher prices posed by international offerings - many of which were manufactured locally under licence. In fact, the majority of analgesics manufactured locally were owned by international laboratories from France.

Want to find out more about this report?
Request more information
Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Your Recently Viewed Reports

Analgesics in Tunisia

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Analgesics industry in Tunisia with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Analgesics industry in Tunisia, our research will save you time and money while empowering you to make informed, profitable decisions.

The Analgesics in Tunisia market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Analgesics in Tunisia?
  • What are the major brands in Tunisia?
  • Are combination products with acetaminophen still popular?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Analgesics in Tunisia - Category analysis

HEADLINES

PROSPECTS

Self-medication drives growth for analgesics
An increase in choice drives growth for paediatric analgesics
Distribution of analgesics dominated by chemists/pharmacies

COMPETITIVE LANDSCAPE

2019 shows positive results for Sanofi-Aventis Pharma
Lack of innovation in analgesics as major players suffer against cheap alternatives
Manufacturing global brands locally remains a solution to rising prices

CATEGORY DATA

Table 1 Sales of Analgesics by Category: Value 2014-2019
Table 2 Sales of Analgesics by Category: % Value Growth 2014-2019
Table 3 NBO Company Shares of Analgesics: % Value 2015-2019
Table 4 LBN Brand Shares of Analgesics: % Value 2016-2019
Table 5 Forecast Sales of Analgesics by Category: Value 2019-2024
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2019-2024

Consumer Health in Tunisia - Industry Overview

EXECUTIVE SUMMARY

A low supply of medication and health and wellbeing shaped consumer health
Steady growth for most of consumer health as Tunisians self-medicate
Threats to consumer health include the advertising ban and illegal products
Most consumer healthcare products are purchased in chemists/pharmacies
Positive results will be sustained across the forecast period

MARKET INDICATORS

Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2014-2019
Table 8 Life Expectancy at Birth 2014-2019

MARKET DATA

Table 9 Sales of Consumer Health by Category: Value 2014-2019
Table 10 Sales of Consumer Health by Category: % Value Growth 2014-2019
Table 11 NBO Company Shares of Consumer Health: % Value 2015-2019
Table 12 LBN Brand Shares of Consumer Health: % Value 2016-2019
Table 13 Distribution of Consumer Health by Format: % Value 2014-2019
Table 14 Distribution of Consumer Health by Format and Category: % Value 2019
Table 15 Forecast Sales of Consumer Health by Category: Value 2019-2024
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2019-2024

APPENDIX

OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches

DEFINITIONS

SOURCES

Summary 1 Research Sources